glp 1 nausea mechanism Comparing the anorexigenic effects and mechanisms of gut-derived GLP-1 and its receptor agonists: insights into incretin-based therapies for obesity | Diabetology International Glucagon-Like Peptide-1 Based Therapies: A

Eur Heart J 2009;30(22):2769812

Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats

J Clin Endocrinol Metab 87: 489-499 Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, et al

The first product to utilize the microgel technology is Boost Pre-Meal Hunger Support, a liquid shot formulated to help manage hunger

Medications that work on 3 different receptors (GLP-1, GIP, and glucagon) are coming down the pipeline

The breadth of documented activity reflects what the original investigators have described as systems-level pharmacology: rather than acting through a single high-affinity receptor, BPC-157 appears to modulate multiple intersecting cellular pathways including nitric oxide signalling, growth-factor receptor expression, dopamine and serotonin metabolism, and angiogenic vessel formation